计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A124691-5mg |
5mg |
现货 ![]() |
| |
| A124691-25mg |
25mg |
现货 ![]() |
| |
| A124691-50mg |
50mg |
现货 ![]() |
| |
| A124691-250mg |
250mg |
现货 ![]() |
| |
| A124691-1g |
1g |
现货 ![]() |
| |
| A124691-5g |
5g |
现货 ![]() |
| |
| A124691-25g |
25g |
现货 ![]() |
|
| 别名 | N-[2-(7-甲氧基-1-萘基)乙基]乙酰胺 |
|---|---|
| 英文别名 | Agomelatine [INN:BAN] | F0001-2383 | HMS3654B07 | N-(2-(7-Methoxynaphth-1-yl)ethyl)acetamide | Q-102507 | Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]- | Agomelatine [INN] | N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide | PDSP1_001305 | GTPL198 | Melitor |
| 规格或纯度 | Moligand™, ≥98%(HPLC) |
| 英文名称 | Agomelatine |
| 生化机理 | 阿戈美拉汀是人和猪血清素(5-HT2C)受体(pKi 分别为 6.2 和 6.4)以及人 5-HT2B 受体(pKi 为 6.6)的竞争性拮抗剂。由于它能拮抗 5-HT2C 受体,因此被归类为去甲肾上腺素-多巴胺抑制剂(NDDI)。血清素激活 5-HT2C 受体会抑制多巴胺和去甲肾上腺素的释放。拮抗 5-HT2C 会增强 DA 和 NE 的释放以及前皮质多巴胺能和肾上腺素能通路的活性。阿戈美拉汀还是褪黑激素受体的强效激动剂,这使它成为第一种褪黑激素抗抑郁药。阿戈美拉汀(Agomelatine)是一种抗抑郁药,具有 MT 1 /MT 2 效应(K i 值分别为 0.1 和 0.12 nM)。5-HT 2C 拮抗剂(IC 50 = 270 nM)。在体内具有抗抑郁作用。口服有效。 |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 激动剂 |
| 作用机制 | 羟色胺 2c (5-HT2c) 受体拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions throμgh all three receptors. Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions through all three receptors. |
| 纯度 | ≥98%(HPLC) |
| ALogP | 2.7 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488186059 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide |
| INCHI | 1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17) |
| InChi Key | YJYPHIXNFHFHND-UHFFFAOYSA-N |
| Smiles | CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC |
| Isomeric SMILES | CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC |
| 分子量 | 243.3 |
| Reaxy-Rn | 5813634 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=5813634&ln= |
| 溶解性 | 可溶于甲醇 |
|---|---|
| 敏感性 | 对热敏感 |
| 熔点 | 110 °C |
| 分子量 | 243.300 g/mol |
| XLogP3 | 2.700 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 243.126 Da |
| 单同位素质量Monoisotopic Mass | 243.126 Da |
| 拓扑极表面积Topological Polar Surface Area | 38.300 Ų |
| 重原子数Heavy Atom Count | 18 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 280.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07, GHS09 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 H400: 对水生生物有剧毒 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P391: 收集溢出物 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| WGK Germany | 3 |
| Merck Index | 190 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 | |
| 分析证书 | A124691 |
| 1. Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaër E. (2014) Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.. Br J Pharmacol, 171 (15): (3604-19). [PMID:24724693] |
| 2. Lan Tian, Wu Yuhan, Zhang Yulei, Li Shuhan, Zhu Zhanpeng, Wang Liyan, Mao Xueqin, Li Ye, Fan Cuiqin, Wang Wenjing, Yu Shu Yan. (2022) Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway. Journal of Neuroinflammation, 19 (1): (1-14). [PMID:35610704] [10.1186/s12974-022-02479-x] |
| 3. Yang Xiao-bo, Zu Heng-bing, Zhao Yong-fei, Yao Kai. (2022) Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice. Frontiers in Aging Neuroscience, 13 (980). [PMID:35153715] [10.3389/fnagi.2021.766410] |
| 4. Xiujuan Chen, Shuiqing Zheng, Jian Le, Zheyuan Qian, Runsheng Zhang, Zhanying Hong, Yifeng Chai. (2017) Ultrasound-assisted low-density solvent dispersive liquid–liquid microextraction for the simultaneous determination of 12 new antidepressants and 2 antipsychotics in whole blood by gas chromatography–mass spectrometry. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 142 (19). [PMID:28494335] [10.1016/j.jpba.2017.04.032] |
| 5. Wei Zhang, Xingwang Ji, Qianyanqiu Zhao, Jinyao Qi, Wen Guo, Gaoshuo Zhang, Yujing Guan, Shenglong Li, Yuling Mao. (2025) Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway. Advanced Science, (2408908). [PMID:39998409] [10.1002/advs.202408908] |